Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial.
Poortmans PM, Weltens C, Fortpied C, Kirkove C, Peignaux-Casasnovas K, Budach V, van der Leij F, Vonk E, Weidner N, Rivera S, van Tienhoven G, Fourquet A, Noel G, Valli M, Guckenberger M, Koiter E, Racadot S, Abdah-Bortnyak R, Van Limbergen EF, Engelen A, De Brouwer P, Struikmans H, Bartelink H; European Organisation for Research and Treatment of Cancer Radiation Oncology and Breast Cancer Groups. Poortmans PM, et al. Among authors: van limbergen ef, van der leij f, van tienhoven g. Lancet Oncol. 2020 Dec;21(12):1602-1610. doi: 10.1016/S1470-2045(20)30472-1. Epub 2020 Nov 2. Lancet Oncol. 2020. PMID: 33152277 Clinical Trial.
Predictive factors for local recurrence in breast cancer.
van der Leij F, Elkhuizen PH, Bartelink H, van de Vijver MJ. van der Leij F, et al. Among authors: van de vijver mj. Semin Radiat Oncol. 2012 Apr;22(2):100-7. doi: 10.1016/j.semradonc.2011.12.001. Semin Radiat Oncol. 2012. PMID: 22385917 Review.
Target volume delineation in external beam partial breast irradiation: less inter-observer variation with preoperative- compared to postoperative delineation.
van der Leij F, Elkhuizen PH, Janssen TM, Poortmans P, van der Sangen M, Scholten AN, van Vliet-Vroegindeweij C, Boersma LJ. van der Leij F, et al. Among authors: van vliet vroegindeweij c, van der sangen m. Radiother Oncol. 2014 Mar;110(3):467-70. doi: 10.1016/j.radonc.2013.10.033. Epub 2013 Nov 18. Radiother Oncol. 2014. PMID: 24262820
First results of the preoperative accelerated partial breast irradiation (PAPBI) trial.
van der Leij F, Bosma SC, van de Vijver MJ, Wesseling J, Vreeswijk S, Rivera S, Bourgier C, Garbay JR, Foukakis T, Lekberg T, van den Bongard DH, van Vliet-Vroegindeweij C, Bartelink H, Rutgers EJ, Elkhuizen PH. van der Leij F, et al. Among authors: van vliet vroegindeweij c, van de vijver mj, van den bongard dh. Radiother Oncol. 2015 Mar;114(3):322-7. doi: 10.1016/j.radonc.2015.02.002. Epub 2015 Feb 17. Radiother Oncol. 2015. PMID: 25701298 Free article. Clinical Trial.
Very low local recurrence rates after breast-conserving therapy: analysis of 8485 patients treated over a 28-year period.
Bosma SC, van der Leij F, van Werkhoven E, Bartelink H, Wesseling J, Linn S, Rutgers EJ, van de Vijver MJ, Elkhuizen PH. Bosma SC, et al. Among authors: van werkhoven e, van der leij f, van de vijver mj. Breast Cancer Res Treat. 2016 Apr;156(2):391-400. doi: 10.1007/s10549-016-3732-0. Epub 2016 Mar 23. Breast Cancer Res Treat. 2016. PMID: 27008183
Response to Preoperative Radiation Therapy in Relation to Gene Expression Patterns in Breast Cancer Patients.
Bosma SCJ, Hoogstraat M, van der Leij F, de Maaker M, Wesseling J, Lips E, Loo CE, Rutgers EJ, Elkhuizen PHM, Bartelink H, van de Vijver MJ. Bosma SCJ, et al. Among authors: van der leij f, van de vijver mj. Int J Radiat Oncol Biol Phys. 2020 Jan 1;106(1):174-181. doi: 10.1016/j.ijrobp.2019.09.002. Epub 2019 Sep 13. Int J Radiat Oncol Biol Phys. 2020. PMID: 31525407
A case-control study to identify molecular risk factors for local recurrence in young breast cancer patients.
Bosma SCJ, Hoogstraat M, van Werkhoven E, de Maaker M, van der Leij F, Elkhuizen PHM, Fourquet A, Poortmans P, Boersma LJ, Bartelink H, van de Vijver MJ; Young Boost Trial research group. Bosma SCJ, et al. Among authors: van werkhoven e, van der leij f, van de vijver mj. Radiother Oncol. 2021 Mar;156:127-135. doi: 10.1016/j.radonc.2020.11.025. Epub 2020 Nov 24. Radiother Oncol. 2021. PMID: 33245949 Clinical Trial.
Evaluation of Early Response to Preoperative Accelerated Partial Breast Irradiation (PAPBI) by Histopathology, Magnetic Resonance Imaging, and 18F-fluorodexoyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT).
Bosma SCJ, van der Leij F, Elkhuizen PHM, Vreeswijk S, Loo CE, Vogel WV, Bartelink H, van de Vijver MJ. Bosma SCJ, et al. Among authors: van der leij f, van de vijver mj. Int J Radiat Oncol Biol Phys. 2021 Jul 15;110(4):1151-1158. doi: 10.1016/j.ijrobp.2021.02.033. Epub 2021 Feb 26. Int J Radiat Oncol Biol Phys. 2021. PMID: 33647369
Corrigendum to "A case-control study to identify molecular risk factors for local recurrence in young breast cancer patients" [Radiother Oncol 156 (2021) 127-135].
Bosma SCJ, Hoogstraat M, van Werkhoven E, de Maaker M, van der Leij F, Elkhuizen PHM, Fourquet A, Poortmans P, Boersma LJ, Bartelink H, van de Vijver MJ; Young Boost Trial research group. Bosma SCJ, et al. Among authors: van werkhoven e, van der leij f, van de vijver mj. Radiother Oncol. 2021 Oct;163:244. doi: 10.1016/j.radonc.2021.03.037. Epub 2021 Jun 10. Radiother Oncol. 2021. PMID: 34120786 No abstract available.
71 results